Background: Poor medication compliance by human epilepsy patients is one of the leading causes of treatment failure and increased seizure frequency. The aim of this cross-sectional study was to analyse owner compliance in pharmacological treatment of canine idiopathic epilepsy and to identify factors associated with poor compliance. Methods: The number of antiseizure drug tablets was recorded to determine if the patient received sufficient tablets to cover the time period between prescriptions and to assess compliant prescription cycles. Additionally, compliance was assessed by an online survey of owners. Results: For the prescription monitoring data from 94 cases from three small animal practices in the United Kingdom revealed an overall median compliance of 56%. Thirty-three per cent of owners were ≥80% compliant, while 21% were 100% compliant. During a non-compliant prescription cycle, a patient missed a median of 6 days (0.11-519 days) of treatment. Patients on polytherapy had higher compliance rates than on monotherapy (p = 0.031). The survey (229 respondents from online canine epilepsy groups) showed that low daily dosing was associated with better compliance (p = 0.049). Conclusion: Owner compliance was subpar in this study and could represent a significant issue in epilepsy management, which needs to be considered by veterinary surgeons when treating canine epilepsy.
BSAVA CONGRESS 2017 PROCEEDINGS [ 475 ] (involved in axonal guidance) and heat shock protein HSP70 (protecting cells from stress). Western blot confirmed presence of these proteins in all 6 samples analysed. However, there was no difference in protein density between 'responders' and 'non-responders'. OEC immunocytochemistry revealed strong hnRNPa2 nuclear labeling and moderate CRMP4 and HSP70 cytoplasmic labeling. STATEMENT We have identified three proteins involved in neural function that might play a role in OEC transplant efficacy. Further work is needed to validate these preliminary findings but this suggests that genetically modifying OECs to over-express these proteins could enhance their efficacy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.